Found: 17
Select item for more details and to access through your institution.
Direct comparison of SARS-CoV-2 variant specific neutralizing antibodies in human and hamster sera.
- Published in:
- NPJ Vaccines, 2024, v. 9, n. 1, p. 1, doi. 10.1038/s41541-024-00888-y
- By:
- Publication type:
- Article
Detection of infectious SARS-CoV-2 in ocular samples is linked to viral load in the nasopharynx.
- Published in:
- Frontiers in Cellular & Infection Microbiology, 2024, p. 01, doi. 10.3389/fcimb.2024.1332157
- By:
- Publication type:
- Article
Durability of Cross-Neutralizing Antibodies 5.5 Months After Bivalent Coronavirus Disease 2019 Vaccine Booster.
- Published in:
- Journal of Infectious Diseases, 2024, v. 229, n. 3, p. 644, doi. 10.1093/infdis/jiad472
- By:
- Publication type:
- Article
B and T Cell Responses to SARS-CoV-2 Vaccination in Kidney and Liver Transplant Recipients with and without Previous COVID-19.
- Published in:
- Viruses (1999-4915), 2024, v. 16, n. 1, p. 1, doi. 10.3390/v16010001
- By:
- Publication type:
- Article
Antiviral Potential of Azelastine against Major Respiratory Viruses.
- Published in:
- Viruses (1999-4915), 2023, v. 15, n. 12, p. 2300, doi. 10.3390/v15122300
- By:
- Publication type:
- Article
Characterizing SARS-CoV-2 neutralization profiles after bivalent boosting using antigenic cartography.
- Published in:
- Nature Communications, 2023, v. 14, n. 1, p. 1, doi. 10.1038/s41467-023-41049-4
- By:
- Publication type:
- Article
Retained avidity despite reduced cross-binding and cross-neutralizing antibody levels to Omicron after SARS-COV-2 wild-type infection or mRNA double vaccination.
- Published in:
- Frontiers in Immunology, 2023, p. 1, doi. 10.3389/fimmu.2023.1196988
- By:
- Publication type:
- Article
BA.2 and BA.5 omicron differ immunologically from both BA.1 omicron and pre-omicron variants.
- Published in:
- Nature Communications, 2022, v. 13, n. 1, p. 1, doi. 10.1038/s41467-022-35312-3
- By:
- Publication type:
- Article
Regimen of Coronavirus Disease 2019 Vaccination Influences Extent and Kinetics of Antibody Avidity.
- Published in:
- Journal of Infectious Diseases, 2022, v. 226, n. 11, p. 1909, doi. 10.1093/infdis/jiac379
- By:
- Publication type:
- Article
High Prevalence of Undocumented SARS-CoV-2 Infections in the Pediatric Population of the Tyrolean District of Schwaz.
- Published in:
- Viruses (1999-4915), 2022, v. 14, n. 10, p. N.PAG, doi. 10.3390/v14102294
- By:
- Publication type:
- Article
The Anti-Histamine Azelastine, Identified by Computational Drug Repurposing, Inhibits Infection by Major Variants of SARS-CoV-2 in Cell Cultures and Reconstituted Human Nasal Tissue.
- Published in:
- Frontiers in Pharmacology, 2022, v. 13, p. 1, doi. 10.3389/fphar.2022.861295
- By:
- Publication type:
- Article
12-month SARS-CoV-2 antibody persistency in a Tyrolean COVID-19 cohort.
- Published in:
- Wiener Klinische Wochenschrift, 2021, v. 133, n. 23/24, p. 1265, doi. 10.1007/s00508-021-01985-x
- By:
- Publication type:
- Article
Marked increase in avidity of Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2) antibodies 7-8 months after infection is not diminished in old age.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Characterization of Immune Responses to SARS-CoV-2 and Other Human Pathogenic Coronaviruses Using a Multiplex Bead-Based Immunoassay.
- Published in:
- Vaccines, 2021, v. 9, n. 6, p. 611, doi. 10.3390/vaccines9060611
- By:
- Publication type:
- Article
Comparison of Four SARS-CoV-2 Neutralization Assays.
- Published in:
- Vaccines, 2021, v. 9, n. 1, p. 13, doi. 10.3390/vaccines9010013
- By:
- Publication type:
- Article
Oncolytic virotherapy enhances the efficacy of a cancer vaccine by modulating the tumor microenvironment.
- Published in:
- International Journal of Cancer, 2019, v. 145, n. 7, p. 1958, doi. 10.1002/ijc.32325
- By:
- Publication type:
- Article
Fcγ Receptor Type I (CD64)-Mediated Impairment of the Capacity of Dendritic Cells to Activate Specific CD8 T Cells by IgG-opsonized Friend Virus.
- Published in:
- Viruses (1999-4915), 2019, v. 11, n. 2, p. 145, doi. 10.3390/v11020145
- By:
- Publication type:
- Article